PROMOTION OF MEGAKARYOCYTE PROGENITOR EXPANSION AND DIFFERENTIATION BY THE C-MPL LIGAND THROMBOPOIETIN

被引:940
作者
KAUSHANSKY, K [1 ]
LOK, S [1 ]
HOLLY, RD [1 ]
BROUDY, VC [1 ]
LIN, N [1 ]
BAILEY, MC [1 ]
FORSTROM, JW [1 ]
BUDDLE, MM [1 ]
OORT, PJ [1 ]
HAGEN, FS [1 ]
ROTH, GJ [1 ]
PAPAYANNOPOULOU, T [1 ]
FOSTER, DC [1 ]
机构
[1] ZYMOGENET INC,SEATTLE,WA 98105
关键词
D O I
10.1038/369568a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
THE development of blood cells including expansion of megakaryocyte progenitor cells requires the interplay of marrow stromal cells and polypeptide cytokines(1-10). Recently, characterization of c-Mpl, the receptor encoded by the proto-oncogene c-mpl, revealed structural homology with the haematopoietic cytokine receptor family(11), and its involvement in megakaryocyte development(12). We report here that the ligand for c-Mpl(13) is relatively lineage specific, works both alone and synergistically with early acting cytokines to support megakaryocyte colony formation, and acts at a late stage of development to increase megakaryocyte size, polyploidization and expression of differentiation markers. In vivo, c-Mpl ligand stimulates platelet production by greatly expanding marrow and splenic megakaryocytes and their progenitors, and by shifting the distribution of megakaryocyte ploidy to higher values. Thus, as c-Mpl ligand has the expected characteristics of the major regulator of megakaryocyte development, we propose that it be termed thrombopoietin.
引用
收藏
页码:568 / 571
页数:4
相关论文
共 28 条
[1]   SELECTIVE GROWTH-RESPONSE TO IL-3 OF A HUMAN-LEUKEMIC CELL-LINE WITH MEGAKARYOBLASTIC FEATURES [J].
AVANZI, GC ;
LISTA, P ;
GIOVINAZZO, B ;
MINIERO, R ;
SAGLIO, G ;
BENETTON, G ;
CODA, R ;
CATTORETTI, G ;
PEGORARO, L .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (03) :359-366
[2]  
AVRAHAM H, 1992, BLOOD, V80, P1679
[3]   RECOMBINANT HUMAN ERYTHROPOIETIN - PURIFICATION AND ANALYSIS OF CARBOHYDRATE LINKAGE [J].
BROUDY, VC ;
TAIT, JF ;
POWELL, JS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1988, 265 (02) :329-336
[4]  
BURSTEIN SA, 1992, EXP HEMATOL, V20, P1170
[5]   ISOLATION AND CHARACTERIZATION OF THE ALPHA-CHAIN AND BETA-CHAIN OF HUMAN-PLATELET GLYCOPROTEIN-IB [J].
CANFIELD, VA ;
OZOLS, J ;
NUGENT, D ;
ROTH, GJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 147 (02) :526-534
[6]  
CARRINGTON PA, 1991, BLOOD, V77, P34
[7]  
CHOW FPR, 1993, EXP HEMATOL, V21, P255
[8]   EFFECTS OF THE RECOMBINANT HEMATOPOIETIC GROWTH-FACTORS INTERLEUKIN-3, INTERLEUKIN-6, STEM-CELL FACTOR, AND LEUKEMIA INHIBITORY FACTOR ON THE MEGAKARYOCYTIC DIFFERENTIATION OF CD34+ CELLS [J].
DEBILI, N ;
MASSE, JM ;
KATZ, A ;
GUICHARD, J ;
BRETONGORIUS, J ;
VAINCHENKER, W .
BLOOD, 1993, 82 (01) :84-95
[9]   ENDOPROTEOLYTIC PROCESSING OF THE HUMAN PROTEIN-C PRECURSOR BY THE YEAST KEX2 ENDOPEPTIDASE COEXPRESSED IN MAMMALIAN-CELLS [J].
FOSTER, DC ;
HOLLY, RD ;
SPRECHER, CA ;
WALKER, KM ;
KUMAR, AA .
BIOCHEMISTRY, 1991, 30 (02) :367-372
[10]   INVIVO SYNERGISM OF RECOMBINANT HUMAN INTERLEUKIN-3 AND RECOMBINANT HUMAN INTERLEUKIN-6 ON THROMBOPOIESIS IN PRIMATES [J].
GEISSLER, K ;
VALENT, P ;
BETTELHEIM, P ;
SILLABER, C ;
WAGNER, B ;
KYRLE, P ;
HINTERBERGER, W ;
LECHNER, K ;
LIEHL, E ;
MAYER, P .
BLOOD, 1992, 79 (05) :1155-1160